Assignee
Opna Bio SA
CH·4 granted patents·7 pending applications·2 citations·filing 2021–2025
Top patents by PatentIndex Score
11 records- 0183US11807626B2Compounds and methods for CD73 modulation and indications thereforOpna Bio SA·Filed 2021·Granted Nov 7, 2023·1 cites·40 claims
- 0279US12116365B2Heterocyclic compounds and uses thereofOpna Bio SA·Filed 2022·Granted Oct 15, 2024·0 cites·16 claims
- 0377US2024174659A1Compounds and methods for yap/tead modulation and indications thereforOpna Bio SA·Filed 2023·Application pending·0 cites
- 0474US11628176B2Combinational drug therapiesOpna Bio SA·Filed 2021·Granted Apr 18, 2023·1 cites·25 claims
- 0573US12202818B2Compounds and methods for CD73 modulation and indications thereforOpna Bio SA·Filed 2023·Granted Jan 21, 2025·0 cites·31 claims
- 0664US2025129028A1Compounds and methods for yap/tead modulation and indications thereforOpna Bio SA·Filed 2024·Application pending·0 cites
- 0744US2025382279A1Compounds and methods for yap/tead modulation and indications thereforOpna Bio SA·Filed 2025·Application pending·0 cites
- 0844US2025368614A1Compounds and methods for yap/tead modulation and indications thereforOpna Bio SA·Filed 2025·Application pending·0 cites
- 0944US2025382293A1Compounds and methods for yap/tead modulation and indications thereforOpna Bio SA·Filed 2025·Application pending·0 cites
- 1044US2025376445A1Compounds and methods for yap/tead modulation and indications thereforOpna Bio SA·Filed 2025·Application pending·0 cites
- 1144US2025376458A1Compounds and methods for yap/tead modulation and indications thereforOpna Bio SA·Filed 2025·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →